Navigation Links
Mouse gene shows new mechanism behind cardiac infarction in man

A gene that, in different variants, increases or decreases the level of atherosclerosis has been identified in mice. The corresponding human gene has been shown to play a role in the development of myocardial infarction.

The results of the study is published this week on Nature Genetics Online.

Researchers at Karolinska Institutet, in collaboration with the Jackson Laboratory in the USA, AstraZeneca and a Japanese research group, have scrutinised an area on chromosome 1 that is of demonstrable importance to the development of arteriosclerosis. The TNFSF4 gene was identified as the one responsible, as mice with mutations in this gene displayed a lower degree of atherosclerosis, while mice with more active variants of the gene displayed the opposite.

Studies of two patient groups revealed that a certain variant of the human homologue of the gene was more common in people who had a history of cardiac infarction than those without.

“This is an example of how an unbiased genetic strategy based on a mice model can teach us more about common human diseases,?says researcher Jacob Lagercrantz of the Gustav V research institute, Karolinska Institutet.

The gene codes for a protein called OX40L, which is involved in the activation of immunological T cells. These cells, in turn, play an important role in the pathogenesis of atherosclerosis and of a number of chronic inflammatory diseases. The new finding will spur further research into the relationship between the protein and cardiac infarction. Hopefully it will offer a new therapeutic technique for the treatment of atherosclerosis and thus reduce the risk of cardiac infarction.


'"/>

Source:News-Medical


Page: 1

Related biology news :

1. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
2. Mouse brain tumors mimic those in human genetic disorder
3. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
4. Mouse with designer liver has enhanced glucose tolerance, insulin response
5. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
6. Mouse genome much more complex than expected
7. Mouse study: New muscle-building agent beats all previous ones
8. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
9. Mouse to man: The story of chromosomes
10. Mouse mimics chronic leukemia, will aid drug development
11. Mouse study reveals new clues about virulence of 1918 influenza virus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... ... Worldwide Business with kathy ireland® has announced an exclusive interview with ... and Marketing Jeff Maier to discuss their innovative technology, High-Speed Vibration Therapy. The segment ... at 5:30 p.m. EST and internationally on Bloomberg Television on Saturday, Jan. 25, 2020 ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... lead the company’s new Business Development Department. The move, which is part of ... been previously serving as the company’s Senior Vice President where he oversaw its ...
(Date:1/8/2020)... ... 2020 , ... R3 Stem Cell, the nation's leader in ... practice network partners. Not only does this save practices considerable monies on the ... themselves are less expensive. , Since the regenerative biologics mostly require dry ice ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... to be the exclusive distributor to food and beverage manufactures within North America. ... considered critical suppliers. This agreement will allow each company to pool their collective ...
(Date:1/27/2020)... ... January 27, 2020 , ... ... has secured financing from strategic investors led by Halma plc , a ... investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative from ...
(Date:1/23/2020)... , ... January 22, 2020 , ... ... developments in the cosmetic surgery industry at two recent North American investor forums ... at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 ...
(Date:1/22/2020)... ... ... QCDx , a private biotech company that has developed a breakthrough ... sale of the proprietary RareScope™ instrument to the Carole and Ray Neag Comprehensive Cancer ... , “The RareScope can detect and isolate intact and live Circulating Tumor Cells from ...
Breaking Biology Technology: